AbbVie Net Worth 2010-2020 | ABBV

Interactive chart of historical net worth (market cap) for AbbVie (ABBV) over the last 10 years. How much a company is worth is typically represented by its market capitalization, or the current stock price multiplied by the number of shares outstanding. AbbVie net worth as of May 29, 2020 is $136.85B.
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $136.850B $33.266B
AbbVie is a global, research-based biopharmaceutical company. AbbVie combines the focus and passion of a leading-edge biotech with the expertise and structure of a long-established pharmaceutical leader. The company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases. AbbVie aims to help patients' live healthier lives and collaborate on sustainable healthcare solutions.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $391.896B 16.75
Roche Holding AG (RHHBY) Switzerland $296.882B 0.00
Pfizer (PFE) United States $212.139B 13.17
Merck (MRK) United States $203.745B 14.76
Novartis AG (NVS) Switzerland $200.372B 15.64
Novo Nordisk (NVO) Denmark $155.276B 25.86
Eli Lilly (LLY) United States $146.289B 23.68
AstraZeneca (AZN) United Kingdom $143.291B 29.51
Bristol-Myers Squibb (BMY) United States $135.128B 11.29
Sanofi (SNY) $122.978B 14.23
GlaxoSmithKline (GSK) United Kingdom $105.157B 12.55
Bayer (BAYRY) Germany $63.786B 9.10
H Lundbeck (HLUYY) Denmark $7.631B 13.26
Innoviva (INVA) United States $1.415B 8.17